Michel Orsinger appointed Chief Operating Officer - Third quarter sales growth of 18.7%
Synthes resolves merger control proceedings in Germany – Synthes will be added to the SMI
Synthes, Inc. announces FDA approval of patented
Vertical Expandable Prosthetic Titanium Rib (VEPTR)
Synthes first half-year 2004:
Pro forma continuing operations sales and profit growth of 23% and 21% (19% and 18% local currencies continuing operations), respectively, driven by new products
SWX Indices: Adjustments to composition of SMI®.
Synthes is awarded the innovation prize "Industrial Logistics 2004"
Name change and share split to be effective on May 24, 2004
Synthes reports first quarter 2004 sales results
Gelifex and Synthes Inc. Unite to Market Product that Promises to Alleviate Spinal Disease
Synthes-Stratec has added the Annual report 2003 to its website
German Cartel Office to prohibit merger of Synthes and Mathys in Germany
Synthes-Stratec proposes changes to its capital structure at this year’s General Meeting of Shareholders
Synthes-Stratec 2003 results:
Sales and profit growth continues
Erwin Locher steps down as COO
Synthes-Stratec Inc. receives statement of objection from German merger control authority
Synthes-Stratec Inc. and Mathys Medizinaltechnik AG announce the closing of their merger creating a Global Synthes Company
Synthes-Stratec announces fourth quarter and calendar year 2003 sales: Accelerated sales growth continues for the fourth quarter 2003
